December 4th, 2013
Each service of the US military posted the lowest number of deaths from motor vehicle accidents in 2012 – although motorcycle-related fatalities continues to be a leading cause of death among service members unrelated to war, according to a new study of a15-year surveillance period.
In 2012, there were 184 motor vehicle-related deaths among service members, according to the study published in the Medical Surveillance Monthly Report, a peer-reviewed journal on illnesses and injuries affecting service members from the Armed Forces Health Surveillance Center (AFHSC). Deaths in 2012 declined nearly 57.8% from a peak of 436 in 2004, the study said.
Dramatic declines in the numbers and rates of non-motorcycle-related MVA deaths were responsible for the fall in rates for all MVA-related deaths. For the entire 14-year surveillance period, slightly over 25% of all motor vehicle-related deaths were due to motorcycle accidents among active and reserve component service members combined. However, as a result of the decline in non-motorcycle-related MVA deaths since 2005, motorcycle-related deaths have become an increasingly higher proportion of all MVA-related deaths in the latter part of the surveillance period.
December 4th, 2013
The acute care system, which includes urgent care and retail clinics, emergency departments, hospitals, and doctors’ offices, reflects the best and worst in American medicine. While acting as a safety net for the under- and uninsured, the system is also fragmented, disconnected, and costly.
In a study published in the December issue of Health Affairs, Jesse Pines, MD, director of the Office of Clinical Practice Innovation at the George Washington University (GW), and co-authors describe strategies to contain acute care costs without sacrificing quality.
“We are in a time of revolutionary change in medicine in this country with great focus on how the healthcare system can deliver greater value, by reducing costs and enhancing quality,” said Pines, who is also a professor of emergency medicine at the GW School of Medicine and Health Sciences and a professor of health policy at the GW School of Public Health and Health Services. “In acute care, there are many ways that we can safely reduce costs, but we have to be very careful that new policies don’t hurt patients or undermine what makes acute care medicine so accessible and life-saving – specifically, care delivered in emergency departments.”
December 4th, 2013
President Barack Obama on Monday announced a boost to funding for research into HIV/AIDS prevention and pledged up to $5 billion to support an international effort aimed at combating HIV/AIDS.
Speaking at the White House to mark World AIDS Day, the president said the United States would contribute $1 for every $2 pledged by other donors over the next three years to support The Global Fund, an international financing institution that fights AIDS, tuberculosis and malaria.
Obama also said he would redirect $100 million into a National Institutes of Health program to research a cure for HIV, the human immunodeficiency virus that causes AIDS.
December 3rd, 2013
Compared to traditional mammography, 3D mammography—digital breast tomosynthesis—found 22% more breast cancers and led to fewer call backs in a large screening study at the Hospital of the University of Pennsylvania (HUP), researchers reported at the annual meeting of the Radiological Society of North America (RSNA).
Emily F. Conant, MD, chief of Breast Imaging the department of Radiology
Conventional digital mammography is the most widely-used screening modality for breast cancer, but may yield suspicious findings that turn out to be false-positives. Such findings are associated with a higher recall rate or biopsy that may be deemed unnecessary.
Tomosynthesis, however, allows for 3-D reconstruction of the breast tissue, giving radiologists a clearer view of breast tissue. And though a relatively new technology, it has shown promise at reducing recall rates in all groups of patients, including younger women and those with dense breast tissue. This study, presented by Emily F. Conant, MD, chief of Breast Imaging the department of Radiology at the Perelman School of Medicine at the University of Pennsylvania, is one of the largest prospective trials in tomosynthesis to date.
December 3rd, 2013
Finding May Help Clinicians Decide Which Men, With An Aberrant Biopsy, Could Benefit from Additional Future Biopsy Screenings.
Researchers from Weill Cornell Medical College have shown that the presence of a particular protein in biopsied prostate tissue substantially increases the likelihood that cancer will develop in that organ. The discovery will likely help providers decide how closely to monitor men potentially at risk for the cancer — among the most confusing and controversial dilemmas in healthcare.
Their findings, reported in the Journal of Clinical Oncology, are the first to quantify, in the setting of a clinical trial, the increased risk of prostate cancer development from the protein ERG.
Traditional means of determining risk of prostate cancer — blood tests for the protein prostate-specific antigen (PSA) and biopsies — do not always correlate well with the chances of dying from the disease. Decisions on what to do with the results of these tests can be unclear, leaving doctors and patients frustrated and unsure of how to proceed.